Topical Treatments for Rheumatoid Arthritis Joint Pain: What Works and What Doesn't

Medically reviewed | Published: | Evidence level: 1A
Topical treatments offer a valuable adjunct to systemic therapy for managing joint pain in rheumatoid arthritis, particularly for patients who cannot tolerate oral NSAIDs. Topical diclofenac and capsaicin remain the most studied options, while newer formulations aim to improve drug penetration into deeper joint structures.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Treatment

Quick Facts

RA Prevalence
~1% of adults worldwide
Top Topical NSAID
Diclofenac gel (FDA-approved)
Capsaicin Mechanism
Depletes substance P

Which Topical Treatments Are Most Effective for Rheumatoid Arthritis Pain?

Quick answer: Topical diclofenac and capsaicin cream are the most evidence-supported topical options for localized RA joint pain relief.

For patients with rheumatoid arthritis (RA), systemic disease-modifying antirheumatic drugs (DMARDs) remain the cornerstone of treatment. However, topical therapies can serve as useful adjuncts for managing localized joint pain, particularly in the hands, wrists, and knees. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), especially diclofenac in gel or solution form, have the strongest evidence base. These formulations deliver anti-inflammatory medication directly to the affected area while minimizing the gastrointestinal side effects associated with oral NSAIDs.

Capsaicin cream, derived from chili peppers, works through a different mechanism — it depletes substance P, a neuropeptide involved in transmitting pain signals. The American College of Rheumatology (ACR) conditionally recommends topical NSAIDs for certain patients, particularly older adults or those with cardiovascular or gastrointestinal risk factors that make oral NSAIDs less suitable. Menthol-based and salicylate-containing topical products are also widely used, though their evidence base is more limited compared to prescription topical NSAIDs.

Are Topical Treatments Enough to Manage RA Pain on Their Own?

Quick answer: No — topical treatments are adjuncts to systemic therapy, not replacements for DMARDs or biologic medications in RA.

It is important to emphasize that rheumatoid arthritis is a systemic autoimmune disease, and topical treatments address symptoms rather than the underlying disease process. Unlike osteoarthritis, where localized joint degeneration is the primary concern, RA involves systemic inflammation that can damage joints progressively if not controlled with appropriate DMARDs, biologics, or targeted synthetic DMARDs such as JAK inhibitors. Topical agents can reduce localized pain and stiffness but do not halt joint destruction or reduce systemic inflammatory markers.

That said, topical therapies play a meaningful role in multimodal pain management. They can reduce the need for higher doses of oral analgesics, minimize polypharmacy risks, and provide rapid-onset relief for flare-ups in accessible joints like fingers and knees. Emerging research is exploring improved drug delivery systems, including nanoparticle-based formulations and microneedle patches, that may enhance penetration through the skin into deeper joint tissues. Patients should discuss topical options with their rheumatologist as part of a comprehensive treatment plan rather than self-managing with over-the-counter products alone.

What Are the Side Effects of Topical Pain Treatments for Arthritis?

Quick answer: Topical treatments generally cause fewer systemic side effects than oral medications, though local skin irritation is common.

The primary advantage of topical treatments is their favorable safety profile compared to oral NSAIDs. Systemic absorption from topical diclofenac, for example, is estimated to be significantly lower than from oral formulations, which substantially reduces the risk of gastrointestinal bleeding, cardiovascular events, and renal toxicity. This makes topical NSAIDs a preferred option for elderly patients or those with comorbidities that preclude systemic NSAID use.

However, topical treatments are not without side effects. The most common adverse reactions include application site irritation, dryness, redness, and occasionally contact dermatitis. Capsaicin cream frequently causes a burning or stinging sensation during initial use, which typically diminishes with regular application over one to two weeks. Patients with sensitive skin or allergies to specific ingredients should perform a patch test before regular use. Additionally, topical NSAIDs should be avoided on broken or damaged skin, and hands should be washed thoroughly after application to prevent accidental contact with eyes or mucous membranes.

Frequently Asked Questions

In most cases, yes. Topical diclofenac is generally safe to use alongside DMARDs and biologic therapies. However, combining it with oral NSAIDs may increase the risk of side effects. Always consult your rheumatologist before adding any topical treatment to your regimen.

Topical NSAIDs like diclofenac gel can provide pain relief within hours of application, though maximum benefit may take one to two weeks of regular use. Capsaicin cream typically requires consistent application for one to two weeks before significant pain reduction is noticed.

OTC options like menthol-based creams and low-concentration capsaicin can provide temporary relief, but prescription-strength topical NSAIDs such as diclofenac gel generally offer more robust evidence of effectiveness for arthritis-related pain. Discuss with your doctor which option is best for your situation.

References

  1. American College of Rheumatology. Guidelines for the Management of Rheumatoid Arthritis. 2021.
  2. Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults. Cochrane Database of Systematic Reviews. 2017.
  3. Everyday Health. Topical Treatments for Managing Joint Pain in Rheumatoid Arthritis. April 2026.